The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
about
The role of vascular endothelial growth factor a polymorphisms in breast cancerIn vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium.Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patientsThe association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health StudyThe role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionCorrelation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy.Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistryPazopanib for the treatment of breast cancer.Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model.Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.Ovarian carcinoma cells effectively inhibit differentiation and maturation of dendritic cells derived from hematopoietic progenitor cells in vitro.Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts.VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials.Assessing Tumor Angiogenesis in Histological Samples.Molecular mechanisms of hormone resistance of breast cancer.
P2860
Q26851522-162DB165-352D-4482-84BF-6F1B76C4F405Q34708511-8F6A6A84-C489-4848-AAE2-06B03ECB3584Q35584239-BE2CAA99-D5B6-4B4F-B4D7-D194EFA341BEQ35587630-FDC99FF3-E064-42F3-A3E5-8ED3B515BCE3Q36416481-C907AB4A-2572-47D2-BB1B-87DD712042B4Q36649036-609C65FD-C0C1-4715-826E-DD2562CD2791Q36807110-D1A37359-BAED-44EA-B1C4-0E9F3882888EQ36907325-CBC9B8FC-6877-4F26-97A6-22A09E4F55D6Q36978021-2768C319-E896-414E-88DC-C87647861480Q37206068-17AE753A-D6F1-4868-9633-219A99B8631EQ37974693-76214231-7202-4F2C-91CA-ED663AA46A49Q38245841-5C2B920C-44D8-47CB-8361-361EDB72B9CDQ38974777-4AC2201E-5747-47AB-83B0-21E21D4CBA0EQ40367465-C5BA3A64-E53C-43AE-A389-F8869B20A4EEQ40411720-AD8914AE-6B2A-4DC7-8015-92204846DD10Q41133540-CD2B143C-F996-4BEC-B8D8-2661ACEAB109Q41186469-06F37BD2-FE5E-4CF0-8B1C-79D08C919B94Q48274997-C374C7AB-1314-47AB-AAB7-664DD87C7720Q51525609-BB2844FA-16EF-4798-AA53-16DEEF523310Q53086084-0381E306-B7B3-4447-A7A3-73A24ECEE991
P2860
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The prognostic value of vascul ...... ive adjuvant systemic therapy.
@ast
The prognostic value of vascul ...... ive adjuvant systemic therapy.
@en
type
label
The prognostic value of vascul ...... ive adjuvant systemic therapy.
@ast
The prognostic value of vascul ...... ive adjuvant systemic therapy.
@en
prefLabel
The prognostic value of vascul ...... ive adjuvant systemic therapy.
@ast
The prognostic value of vascul ...... ive adjuvant systemic therapy.
@en
P2093
P2860
P356
P1476
The prognostic value of vascul ...... eive adjuvant systemic therapy
@en
P2093
J A Foekens
J Geurts-Moespot
L V A M Beex
T H Van Tienoven
V C G Tjan-Heijnen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600555
P407
P50
P577
2002-09-01T00:00:00Z